Navigation Links
Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference
Date:3/26/2008

MOUNTAIN VIEW, Calif., March 26 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development announced today that it will be presenting at B. Riley & Co. 9th Annual Las Vegas Investor Conference on April 2, 2008 at the Palms Las Vegas. Shawn O'Connor, Pharsight's President and CEO, and William Frederick, Senior Vice President and CFO, will be presenting on April 2nd, at 1:30 p.m. PT.

Attendance at the conference is by invitation only. A live audio webcast of the presentation with slides will be broadcast via the Internet. The webcast can be viewed at the company's website under the investor relations section at http://www.pharsight.com.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.c
'/>"/>

SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
2. Pharsights Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
3. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
4. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
5. Pharsight Achieves $7.4 Million in Quarterly Revenue
6. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
7. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
8. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
9. Pharsight Announces 1-For-3 Reverse Stock Split
10. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
11. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... - Softchoice, a leading North American IT solutions and managed services ... two Cisco® Partner Summit Country awards. Cisco ... Partner of the Year for Canada ... Montreal . "We are ... at this year,s conference," said David MacDonald , Softchoice,s ...
(Date:5/1/2015)... According to a new ... Consumables), by Type (Monoclonal, Polyclonal), by Technology (Hybridoma), ... - Analysis & Global Forecast to 2019", published ... Production Market for the forecast period of 2014 ... $2.572 Billion by 2019 from $1.425 Billion in ...
(Date:4/30/2015)... April 30, 2015   Tamir Biotechnology , a ... update on its Ebola antiviral therapy program. ... TMR004, is currently being evaluated and considered by a ... against Ebola. During the first quarter of 2015, the ... To Accelerate The Evaluation of Potential Treatments and Vaccines ...
(Date:4/30/2015)... April 30, 2015 Oxford Finance LLC ("Oxford"), ... life sciences and healthcare services companies, today announced the ... agreement with Celula, Inc., a diagnostic testing company focused ... better patient care and improved outcomes.  Proceeds of the ... expand the commercialization of its products in the U.S. ...
Breaking Biology Technology:Softchoice recognized with two Country Awards at Cisco Partner Summit 2015 2Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4Oxford Finance Provides $10 Million Debt Financing to Celula 2
... 15 A panel of expert judges selected Nikon Instruments, ... second place among the top ten in The Scientist,s ... of invention, vision and utility. The award, the first-ever ... in the past year, acknowledges Nikon,s exclusive PFS system for ...
... Dec. 15 ADVENTRX Pharmaceuticals, Inc. (Amex: ... and commercializing proprietary product candidates primarily for the treatment ... range of strategic options, including the sale or disposition ... a strategic business merger and other transactions that maximize ...
... 15 BioMed Realty Trust, Inc.,(NYSE: BMR ) ... fourth,quarter 2008 dividend of $0.335 per share of common stock. ... common share. , BioMed ... dividend,of $0.46094 per share of the company,s 7.375% Series A ...
Cached Biology Technology:Nikon Instruments Perfect Focus System Wins Second Place in The Scientist's Top Innovations of 2008 Award 2ADVENTRX Exploring Strategic Options 2ADVENTRX Exploring Strategic Options 3ADVENTRX Exploring Strategic Options 4BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends 2
(Date:3/26/2015)... The Granite Club, Canada,s ... announced it has implemented a state-of-the-art access and security ... and staff, while restricting access to authorized users only. ... IMID Access system because it has the perfect combination ... in addition to unparalleled security," said James DiRenzo ...
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... television starting March 30 th . ... New York markets. ... about our new ad campaign following the recent initial shipment ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... W. Finberg, MD, the Richard M. Haidack Professor of ... University of Massachusetts Medical School, is lead investigator on ... predicting how the influenza virus changes and evolves in ... This approach has promise for becoming a pivotal tool ...
... than 3,000 hybrid fish in his time as a graduate ... that has helped him create one of the most comprehensive ... key prediction in evolutionary biology. "We can see a ... new specialized species," said Martin, who with Professor Peter Wainwright ...
... crops such as miscanthus, whose high yields have led ... in producing ethanol, are now shown to have another ... in the environment. In a 4-year University of Illinois ... to typical corn-corn-soybean rotations, each of the perennial crops ...
Cached Biology News:A snapshot of pupfish evolution in action 2Lower nitrogen losses with perennial biofuel crops 2Lower nitrogen losses with perennial biofuel crops 3
Goat Anti-Horse IgG(T) Antibody, Unconjugated...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2...
Rabbit polyclonal to ErbB 2 (phospho Y1248) ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626...
Biology Products: